LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

816.5 0.82

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

808.83

Max

825.32

Schlüsselkennzahlen

By Trading Economics

Einkommen

426M

1.2B

Verkäufe

5.3B

103B

KGV

Branchendurchschnitt

25.703

76.798

EPS

9.86

Dividendenrendite

0.36

Gewinnspanne

1.173

Angestellte

43,000

EBITDA

212M

1.5B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+15.97% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.36%

2.37%

Nächste Dividendenausschüttung

2. Jan. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

338M

102B

Vorheriger Eröffnungskurs

815.68

Vorheriger Schlusskurs

816.5

Nachrichtenstimmung

By Acuity

43%

57%

151 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Dez. 2025, 23:54 UTC

Heiße Aktien

Stocks to Watch: Nike, Cassava Sciences, KB Home

18. Dez. 2025, 23:51 UTC

Ergebnisse

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18. Dez. 2025, 23:39 UTC

Wichtige Markttreiber

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18. Dez. 2025, 22:57 UTC

Akquisitionen, Fusionen, Übernahmen

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18. Dez. 2025, 21:40 UTC

Ergebnisse

Nike Sales Tick Up, But China Weakness Persists

18. Dez. 2025, 23:45 UTC

Market Talk

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18. Dez. 2025, 23:37 UTC

Market Talk
Ergebnisse

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18. Dez. 2025, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18. Dez. 2025, 23:03 UTC

Akquisitionen, Fusionen, Übernahmen

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18. Dez. 2025, 23:02 UTC

Akquisitionen, Fusionen, Übernahmen

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18. Dez. 2025, 23:00 UTC

Akquisitionen, Fusionen, Übernahmen

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18. Dez. 2025, 22:59 UTC

Akquisitionen, Fusionen, Übernahmen

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18. Dez. 2025, 22:58 UTC

Akquisitionen, Fusionen, Übernahmen

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18. Dez. 2025, 22:57 UTC

Akquisitionen, Fusionen, Übernahmen

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18. Dez. 2025, 22:56 UTC

Akquisitionen, Fusionen, Übernahmen

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18. Dez. 2025, 22:55 UTC

Ergebnisse

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18. Dez. 2025, 21:59 UTC

Ergebnisse

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18. Dez. 2025, 21:50 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

18. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18. Dez. 2025, 21:35 UTC

Ergebnisse

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18. Dez. 2025, 21:31 UTC

Ergebnisse

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Greater China Rev Down 17% >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q EPS 53c >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Apparel Rev $3.91B >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Equipment Rev $550M >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q N Amer Rev $5.63B >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Footwear Rev $7.66B >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18. Dez. 2025, 21:15 UTC

Ergebnisse

Nike 2Q Greater China Rev $1.42B >NKE

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

15.97% Vorteil

12-Monats-Prognose

Durchschnitt 935.33 USD  15.97%

Hoch 1,000 USD

Tief 860 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

15 ratings

13

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

151 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat